Pulse Biosciences, Inc. Increase (Decrease) in Other Operating Assets
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Other Operating Assets of -$129.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2022-03-31
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2020-12-31 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2020-06-30 was -$197.00K, a 107.52% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2020-03-31 was $68.00K, a 36.45% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2020 was -$129.00K, a 132.82% decline from fiscal 2019.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2019 was $393.00K.
- Pulse Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2017 was $101.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | -$197.00K derived: sum of 3 quarters · filed 2022-03-31 | -$129.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$197.00K derived: sum of 2 quarters · filed 2021-11-15 | -$129.00K 10-Q · filed 2021-11-15 | -$2.47M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | -$197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$129.00K 10-Q · filed 2021-08-09 | -$2.47M derived: sum of 3 quarters · filed 2022-03-31 | -$2.46M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $68.00K 10-Q · filed 2021-05-10 | -$2.27M derived: sum of 2 quarters · filed 2022-03-31 | -$2.27M derived: sum of 3 quarters · filed 2022-03-31 | $354.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$2.33M derived: sum of 2 quarters · filed 2022-03-31 | $286.00K derived: sum of 3 quarters · filed 2022-03-31 | $393.00K 10-K · filed 2022-03-31 |
| 2019-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.63M derived: sum of 2 quarters · filed 2019-11-07 | $2.73M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.73M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $107.00K 10-Q · filed 2020-05-11 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $101.00K 10-K · filed 2020-03-16 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $101.00K 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $101.00K 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |